U.S. Senate Revisits Whether to Keep Protecting Medical Marijuana
By J.J. McCoy, Senior Managing Editor for New Frontier Data
What We Have Learned: Despite uncertainty from continued temporary extensions, industry experts remain cautiously optimistic.
July 27, 2017 -- A voice vote by the Senate Appropriations Committee Thursday approved inclusion of the Senate version of the Rohrabacher-Blumenauer amendment which prevents the federal government from interfering with medical marijuana programs legalized at the state level.
While formal passage of the bill is not expected until the fall, it was being interpreted by some, as detailed by the libertarian magazine and website Reason, as a rejection by the panel's members (including 16 Republicans) to a May 1 letter by U.S. Attorney General Jeff Sessions to let the amendment lapse.
The rider was first passed as the Rohrabacher-Farr amendment in 2014, and since then has been renewed annually.
Today’s action coincides with the expected release of a report by a subcommittee of Sessions’ recently created Task Force on Crime Reduction and Public Safety to review current federal policies “in the areas of charging, sentencing, and marijuana to ensure consistency with the Department's overall strategy on reducing violent crime and with Administration goals and priorities.”
As Hoban Law Group attorney Steve Schain explained, “In this lucrative, yet volatile industry in which the amendment serves as the ultimate firewall from disruption from the federal government, ‘cautiously optimistic’ is how legalized marijuana industry stakeholders are responding to keeping the federal government from interfering with 29 states’ and the District of Columbia’s legalized medical marijuana programs.”
J.J. McCoy is Senior Managing Editor for New Frontier Data. A former staff writer for The Washington Post, he is a career journalist having covered emerging technologies among industries including aviation, satellites, transportation, law enforcement, the Smart Grid and professional sports. He has reported from the White House, the U.S. Senate, three continents and counting.